2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide

We are 2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide CAS:15308-01-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide
CAS.NO:15308-01-7
Synonyms:2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide
N-(2,6-2 Chlorophenyl)-N-phenyl-Chloroacetamide
 
Physical and Chemical Properties:
Density 1.411 g/cm3
Boiling Point 487.5ºC at 760 mmHg
Melting Point 143 – 145ºC
Molecular Formula C14H10Cl3NO
Molecular Weight 314.59400
Flash Point 248.6ºC
Vapour Pressure 1.18E-09mmHg at 25°C
Index of Refraction 1.633
 
Specification:
Appearance:White or almost white crystalline powder
Assay(HPLC):≥99.0%
Melting Point:142 – 148ºC
Loss on drying:≤0.5%
Unknown single impurity:≤0.5%
Total impurities:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Diclofenac sodium(CAS:15307-79-6).

2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide


Related News: If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role.Ethyl 2-bromovalerate CAS:615-83-8 With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. nearTetra-(methylethylketoxime)silane CAS:34206-40-1 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.Acetato de 3-trimetoxisililpropilo CAS:59004-18-1 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.

Related Products
Product Name
4-Bromo-1-butene View Details
Piperidin-3-amine dihydrochloride View Details
1-(1,3-benzodioxol-5-yl)ethanone Cas:3162-29-6 View Details
5-Bromo-2-methoxypyridine manufacturer (R)-(-)-4-Phenyl-2-Oxazolidinone manufacturer 2-Methylimidazole manufacturer N-Phenylglycine manufacturer Chromium(III) picolinate manufacturer